Arkema SA (OTCMKTS:ARKAY – Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 306 shares, an increase of 183.3% from the March 15th total of 108 shares. Based on an average daily trading volume, of 10,994 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on ARKAY. Zacks Research cut Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Arkema in a research note on Thursday. Kepler Capital Markets cut shares of Arkema from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 27th. Finally, The Goldman Sachs Group raised shares of Arkema from a “hold” rating to a “buy” rating in a research note on Tuesday, February 10th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Arkema has an average rating of “Reduce”.
Get Our Latest Report on ARKAY
Arkema Stock Performance
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Stories
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
